Home
RAPP
RAPP News

Latest Rapport Therapeutics Inc. Common Stock (RAPP) News on April 2, 2025

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting

GlobeNewswire

12 days ago

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting

Positive Signs As Multiple Insiders Buy Rapport Therapeutics Stock

Simply Wall St.

18 days ago

Positive Signs As Multiple Insiders Buy Rapport Therapeutics Stock

Insider Buying: Rapport Therapeutics Chief Financial Officer Bought US$101k Of Shares

Simply Wall St.

18 days ago

Insider Buying: Rapport Therapeutics Chief Financial Officer Bought US$101k Of Shares

Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire

22 days ago

Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development

GlobeNewswire

a month ago

Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development

Rapport Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

a month ago

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Rapport Therapeutics announces new Phase 1 data for RAP-219

TipRanks

3 months ago

Rapport Therapeutics announces new Phase 1 data for RAP-219

MT Newswires

3 months ago

Rapport Therapeutics Reports Positive Early Data for Epilepsy Drug Candidate

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

GlobeNewswire

3 months ago

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

GlobeNewswire

3 months ago

Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

We're Not Worried About Rapport Therapeutics' (NASDAQ:RAPP) Cash Burn

Simply Wall St.

4 months ago

We're Not Worried About Rapport Therapeutics' (NASDAQ:RAPP) Cash Burn

MT Newswires

4 months ago

Rapport Therapeutics Reports Correlation Between Seizure Biomarker, Clinical Seizures

Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures

GlobeNewswire

4 months ago

Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures

Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting

GlobeNewswire

5 months ago

Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting

Rapport Therapeutics expects cash to fund requirements through 2026

TipRanks

5 months ago

Rapport Therapeutics expects cash to fund requirements through 2026

Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update

GlobeNewswire

5 months ago

Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update

Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November

GlobeNewswire

5 months ago

Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November

Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences

GlobeNewswire

7 months ago

Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences

Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit

GlobeNewswire

7 months ago

Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit

Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update

GlobeNewswire

8 months ago

Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update

Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain

GlobeNewswire

8 months ago

Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain

Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement

GlobeNewswire

10 months ago

Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement

Share on Social Networks: